20233 ⎘
Medicinal preparations containing organic active ingredients; Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
Composition of Athletic and Fitness Supplements, Method for Production and Method for Pulmonary Administration of Same
#302DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#303Methods for treating protozoan infections
#304Delivery of a chemotherapy agent across the blood-brain barrier
#305Substituted bicyclic compounds
#306COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#307Non-Enzymatic Debriding Agent and Method of Use Thereof
#308SOLID DRUG FORM OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE AND COMPOSITIONS, METHODS AND KITS RELATED THERETO
#309Endothelial Facilitation in Neurodegerative Diseases by Cerebral Blood Flow Enhancement
#310COMPOSITIONS AND METHODS FOR THE TREATMENT OF CONSTIPATION AND OTHER AILMENTS OF THE GASTROINTESTINAL SYSTEM
#311COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE THEREOF AS INHIBITORS OF RAN GTPASE
#312Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
#313Use of Ureidomustine (BO-1055) in Cancer Treatment
#314Biaryl urea derivative or salt thereof and preparation process and use for the same
#315Sodium nitrite-containing pharmaceutical compositions
#316Biophotonic compositions for the treatment of otitis externa
#317Compositions and methods for improving nitrogen utilization in a ruminant
#318Applicator system containing a microneedle array which comprises an active ingredient for wound healing
#319HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY
#320Use of aminomethylenecyclohexane-1,3-dione compound
#321KCNQ2-5 CHANNEL ACTIVATOR
#322Fabrication of a suramin-loaded nanoparticle and its application
#323Dosing parameters for CD47 targeting therapies to hematologic malignancies
#324COMPOSITIONS FOR MODULATING PD-1 SIGNAL TRANSDUCTION
#325NOVEL TREATMENT FOR HOT FLUSHES
#326METHODS OF CANCER TREATMENT
#327COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ADRENOCORTICAL ACTIVITY AND/OR EXCESSIVE STEROID PRODUCTION
#328Antifungal compositions
#329Cyclopamine analogs
#330Composition and method of using medicament for treatment of cancers and tumors
#331Methods and compositions for treating ulcers
#332Methods for treating protozoan infections
#333PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THROMBOSIS IN PATIENTS SUFFERING FROM A MYELOPROLIFERATIVE NEOPLASM
#334Methods and Systems for Modulating Hormones and Related Methods, Agents and Compositions
#335PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#336Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#337Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#338Integrin activator checkpoint inhibitor compositions
#339Treatment methods and processes for an infected nail
#340Treating male senescence
#341Omega 3 fatty acids and choline as neuroprotectant in patients with no dementia
#342CAPSAZEPINE ANALOGS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES
#343Methods of use of cyclopamine analogs
#344Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
#345Sodium nitrite-containing pharmaceutical compositions
#346Use of Exemestane for the Treatment of Gastric Cancer
#347Method for ameliorating fibrosis using 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[3-(4-cyanophenoxy)phenyl]urea
#348Formulation and method for increasing oral bioavailability of drugs
#349TREATMENT OF INFLAMMATORY DISORDERS IN NON-HUMAN MAMMALS
#350Compositions and methods for the treatment of meibomian gland dysfunction
#351TREATMENT OF FISH POPULATIONS WITH LUFENURON
#352Combination of an oxidant and a photoactivator for the wounds
#353Methods of improving cell-based therapy
#354Method and formulation for improving roflumilast skin penetration lag time
#355Integrin activator vaccine compositions
#356Methods of administering novel integrin activator vaccine compositions
#357Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#358TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION
#359Methods for treating protozoan infections
#360Methods of intravenous administration of glyburide
#361PDE9 INHIBITORS FOR TREATMENT OF PERIPHERAL DISEASES
#362HISTONE DEACETYLASE AS A MODULATOR OF PDLI EXPRESSION AND ACTIVITY
#363Biaryl urea derivative or salt thereof and preparation process and use for the same
#364Combinatory treatment strategies of cancer based on RNA polymerase I inhibition
#365Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#366Antimicrobial composition
#367Formulations for the treatment of pain
#368Methods and compositions for treating cancer
#369Delivery of a chemotherapy agent across the blood-brain barrier
#370Methods for Treating Pruritis
#371COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#372Compositions and Methods for the Treatment and Prevention of Cancer
#373Omega 3 fatty acids, no releasing compound and vitamin B12 as neuroprotectant in patients with no dementia
#374Therapeutic agent for diabetes
#375Histone deacetylase as a modulator of PDLI expression and activity
#376METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT
#377USE OF CELIPROLOL FOR TREATING VASCULAR EHLERS-DANLOS SYNDROME IN WOMEN DURING PREGNANCY AND PERIPARTUM PERIOD
#378USE OF CELIPROLOL FOR TREATING KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME
#379Delivery of urea to cells of the macula and retina using liposome constructs
#380Anti-fibulin-3 antibodies and uses thereof
#381METHODS OF TREATING OR PREVENTING AMYLOID RELATED IMAGING ABNORMALITIES ASSOCIATED WITH ALZHEIMER'S DISEASE TREATMENT
#382SLOW RELEASE COMPOSITION OF ACTIVE INGREDIENTS
#383Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
#384METHODS AND COMPOSITIONS FOR TREATMENT OF SKIN
#385Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
#386Methods and compositions for treatment of pigmented lesions
#387Compositions and methods for treating Alzheimer's disease and Parkinson's disease
#388Double targeted constructs to affect tumor kill
#389Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
#390KCNQ2-5 channel activator
#391Compositions and methods for the treatment of meibomian gland dysfunction
#392COMPOSITIONS, METHODS, COMBINATION TREATMENTS
#393CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS
#394Compounds and methods of treating infections
#395Combinations of LSD1 inhibitors for the treatment of hematological malignancies
#396Substituted bicyclic compounds
#397MU opioid receptor modulators
#398Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination
#399Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
#400PREVENTION OF VASCULAR AND CARDIAC FIBROSIS VIA IRE1ALPHA INHIBITION
#401Biophotonic compositions for the treatment of otitis externa
#402Biophotonic compositions for treating skin and soft tissue wounds having either or both non-resistant and resistant infections
#403Methods and compositions for detecting hematopoietic and lymphoid tissue cancer cells
#404Use of ureidomustine (BO-1055) in cancer treatment
#405Cyclopamine analogs
#406Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production
#407Method of ameliorating side effects of sickle cell disease treatments
#408Drug for treating or preventing disorder caused by TGF-B signals, and application thereof
#409Hyperkeratotic Skin Condition Treatments And Compositions
#410KCNQ2-5 channel activator
#411hTERT modulators and methods of use
#412Methods of use of cyclopamine analogs
#413Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
#414Combination therapy for metastatic cancer
#415Compositions for delivery of drug combinations
#416Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase
#417Amino-aryl-benzamide compounds and methods of use thereof
#418Compositions and methods for identifying and treating dystonia disorders
#419Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors
#420Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
#421Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
#422Compositions and methods for identifying and treating dystonia disorders
#423Compositions and methods for treating nail infections
#424Sodium nitrite-containing pharmaceutical compositions
#425COMPOSITIONS AND METHOD FOR REGULATING ADIPOSE TISSUE LIPOLYSIS, INSULIN-RESISTANCE, AND HYPERGLYCEMIA
#426Methods and compositions of inhibiting DCN1-UBC12 interaction
#427COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
#428Hyperkeratotic skin condition treatments and compositions
#429Urea derivative and use therefor
#430PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AUTOIMMUNE DISEASES COMPRISING THIOUREA DERIVATIVE
#431Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#432INHIBITORS AND METHODS OF INHIBITING BACTERIAL AND VIRAL PATHOGENS
#433ORAL LIQUID COMPOSITIONS OF GUANFACINE
#434Use of hydroxycarbamide for preventing retinal nonperfusion
#435Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
#436Enhanced erythropoiesis and iron metabolism
#437Methods of improving cell-based therapy
#438ENHANCED BIOAVAILABILITY OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)-PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE
#439Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide
#440METHODS AND COMPOSITIONS FOR TREATING NEPHROPATHY
#441METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES
#442Compositions and methods that modulate phosphorus or enzymes in a companion animal
#443METHOD FOR STRATIFICATION OF MELANOMA PATIENTS BY DETERMINATION OF OXYGEN CONSUMPTION, PPARGC1A, PPARGC1B AND MITF LEVELS
#444Enhanced erythropoiesis and iron metabolism
#445Mesylic acid salt of acylthiourea compound, crystal of the same, and process for producing these
#446EXTENDED RELEASE UREA COMPOSITIONS
#447COMPOSITIONS FOR MODULATING PD-1 SIGNAL TRANSDUCTION
#448Methods and compositions to modulate the gut microbiota and to manage weight
#449Composition including glycosaminoglycan derivative and chemokine receptor activity regulator
#450Compositions and methods for treating alopecia
#451Skin barrier repair and maintenance composition
#452KCNQ potassium channel agonist, and preparation method therefor and use thereof
#453PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#454Compositions and methods for treating Alzheimer's disease and Parkinson's disease
#455DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#456ANTI-PCSK9 COMPOUNDS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
#457METHOD FOR PRODUCING ALKYLAMINE DERIVATIVE AND ITS PRODUCTION INTERMEDIATE OF ALKYLAMINE DERIVATIVE
#458Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#4596-membered cyclic amines or lactames substituted with urea and phenyl
#460USE OF SURAMIN AND ARGINASE INHIBITORS IN MALIGNANT NEOPLASIA
#461Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
#462Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#463Pharmaceutical Oral Dose Formulation and Composition of Matter
#464Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein
#465METHOD FOR TREATING OSTEOPOROSIS
#466Compositions and methods for treatment of pain
#467Multi-Step Connective Tissue Stabilization Method and Stabilized Tissue Formed Thereby
#468TOPICAL COMPOSITIONS
#469Selective histone deactylase 6 inhibitors
#470TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
#471Double targeted constructs to affect tumor kill
#472Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
#473Methods of use of cyclopamine analogs
#474FKBP52 specific androgen receptor inhibitor, MJC13, for use in treating breast cancer
#475Methods of intravenous administration of glyburide
#476Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections
#477N-CARBAMOYLPUTRESCINE TO ENHANCE MUSCLE PROTEIN SYNTHESIS
#478KCNQ2-5 channel activator
#479Methods of treating sickle cell disease and related disorders using fumaric acid esters
#480Methods of intravenous administration of glyburide
#481Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
#482METHODS FOR TREATING A NEUROLOGICAL DISORDER IN A SUBJECT USING INHIBITORS OF HYPOXIA-INDUCIBLE FACTOR (HIF) PROYL HYDROXYLASE
#483Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#484Substituted bicyclic compounds
#485Linear guanidine derivatives, methods of preparation and uses thereof
#486Method for incorporating active agents into a hydrophilic polymer foam
#487Methods for treating protozoan infections
#488Drug coated balloon
#489COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES
#490Capsazepine analogs for the treatment of cancer and other proliferative diseases
#491COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS
#492UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS
#493Enhanced erythropoiesis and iron metabolism
#494PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO
#495Sodium nitrite-containing pharmaceutical compositions
#496Synergistic compositions for treating microbial infections
#497IDO inhibitors
#498Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, AIDs, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#499Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)
#500Enhanced erythropoiesis and iron metabolism
#501COMPOSITIONS AND METHODS FOR TREATMENT OF SICKLE CELL DISEASE
#502Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
#503PHARMACEUTICAL COMPOSITION
#504Urea cream formulations
#505Urea composition and method for producing same
#506Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#507TREATMENT OF AUTISTIC SPECTRUM DISORDER
#508Combination of an oxidant and a photoactivator for the healing of wounds
#509Inhibitors and methods of inhibiting bacterial and viral pathogens
#510Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#511Highly protonated hydronium and peroxymonosulfuric acid as a sanitizing solution
#512COMBINATION THERAPIES FOR THE TREATMENT OF FUNGAL INFECTIONS
#513TREATING BAX(DELTA)2-POSITIVE CANCER WITH CHEMOTHERAPIES TARGETING CASPASE 8
#514Sweetness receptor antagonist
#515Methods for treating or preventing neuroinflammation or autoimmune diseases
#516KCNQ potassium channel agonists, method of preparation and method of use thereof
#517Compositions and methods relating to proliferative diseases
#518Methods for treating occular irritation involving tearing by administering modulators of TRPM8
#519Histone deacetylase 6 inhibition for enhancing T-cell function during anti-tumor response and tumor-peptide vaccination
#520Methods and compositions for treating rosacea
#521Histone deacetylase as a modulator of PDL1 expression and activity
#522Method for treating vaginal dryness by administering transient receptor potential cation channel subfamily M member 8 (TRPM8) receptor agonists
#523Substituted bicyclic compounds
#524COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#525PARASITE CONTROL AGENT FOR PARASITICIDE
#526Selective histone deactylase 6 inhibitors
#527Cyclopamine analogs
#528ENZYMATIC DEBRIDEMENT THERAPY FOR ABNORMAL CELL PROLIFERATION
#529METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF
#530Anti-fibulin-3 antibodies and uses thereof
#531Compositions for treating retinal degeneration and methods of production and use thereof
#532Topical wound treatment method and composition
#533Sodium nitrite-containing pharmaceutical compositions
#534Compounds and methods for treating aberrant adrenocortical cell disorders
#535Sodium nitrite-containing pharmaceutical compositions
#536Methods and systems for modulating hormones and related methods, agents and compositions
#537Compound for treating cancer and diabetes
#538Oral liquid compositions of guanfacine
#539Compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants
#540Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin
#541High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries
#542RIBONUCLEOTIDE REDUCTASE INHIBITORS SENSITIZE TUMOR CELLS TO DNA DAMAGING AGENTS
#543METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION
#544Castration-resistant prostate cancer
#545Sirtuin modulators as inhibitors of cytomegalovirus
#546IDO inhibitors
#547MYELOID DERIVED SUPPRESSOR CELL INHIBITING AGENTS
#548COMBINATION THERAPY FOR TREATING DISORDERS ASSOCIATED WITH EXCESS CORTISOL PRODUCTION
#549Combined application of isothiocyanate compound and anti-cancer medicine
#550Control of Blood Vessel Physiology To Treat Skin Disorders
#551Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#552Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
#553Pharmaceutical combinations for the treatment of cancer
#554Compounds and methods for inhibiting Cif virulence factor
#555IDO inhibitors
#556Multi-targeted Ubenimex prodrug derivative and preparation method and use thereof
#557Selective histone deactylase 6 inhibitors
#558Methods of use of cyclopamine analogs
#559Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
#560Sodium nitrite-containing pharmaceutical compositions
#561Facially Amphiphilic Polymers and Oligomers and Uses Thereof
#562Compositions and methods for treatment of pain
#563Composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa
#564Compositions for delivery of drug combinations
#565TREATMENT FOR DISEASES RELYING ON DISCOVERY THAT THIOREDOXIN MEDIATES NITRIC OXIDE RELEASE IN CELLS
#566Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto
#567Inhibitors and methods of inhibiting bacterial and viral pathogens
#568Compounds and methods of treating infections
#569Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters
#570TREATMENT FOR DIABETES IN PATIENTS WITH INSUFFICIENT GLYCEMIC CONTROL DESPITE THERAPY WITH AN ORAL OR NON-ORAL ANTIDIABETIC DRUG
#571Pesticidal compositions and processes related thereto
#572HIGHLY PROTONATED HYDRONIUM AND CARBAMIDE AS A SKIN SANITIZING AND WOUND HEALING SOLUTION
#573Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide
#574Pesticidal compositions and processes related thereto
#575Acrylamide compounds and use thereof for inhibiting apoptosis
#576Pesticidal compositions and processes related thereto
#577Pesticidal compositions and processes related thereto
#578Methods of intravenous administration of glyburide
#579TRANSGENIC CELL SELECTION
#580Compounds and methods for treating aberrant adrenocortical cell disorders
#581Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
#582Oral antiseptic composition useful for treating oral mucositis
#583Method for treating Chikungunya virus infection
#584Thiourea derivatives
#585Method for incorporating active agents into a hydrophilic polymer foam
#586Use of TRMP8 for treating opthalmic diseases or conditions involving tearing
#587Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
#588Pharmaceutical composition for the treatment of fungal infections
#589Therapeutic compounds and compositions
#590CANCER DIAGNOSTIC AND THERAPEUTIC METHOD TARGETING MOLECULES EXPRESSED IN CANCER STEM CELLS
#591Blood flow promoting agent
#592Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
#593NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING
#594Composition and method of using medicament for treatment of cancers and tumors
#595NEW TREATMENT OF FISH WITH A NANOSUS PENS ION OF LUFENURON OR HEXAFLUMURON
#596Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications
#597Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein
#598COMPOSITION FOR TREATING PSORIASIS
#599Compounds and methods for treating mammalian gastrointestinal microbial infections
#600DUAL-TARGETING DRUG CARRIER AND METHOD FOR FABRICATING THE SAME